Endometriosis Treatments

Find Endometriosis Treatments

Generic Name

Norethindrone Acetate

Brand Names

Sharobel, Galbriela, Junel, Blisovi, Necon, Wera, Nortrel, Dasetta, Norethindrone, Microgestin, Nexesta, Mimvey, Deblitane, Cyonanz, Nylia, Zenchent, Hailey, Orquidea, Mibelas 24, Wymzya, Nortrel 21, Camila, Tri-Legest, Hailey 24, Rhuzdah, ERRIN, Affodel, Xelria, Abigale, Alyacen, Philith, Microgestin 24, Nortrel 28, Loestrin, Taytulla, Junel 21, Aurovela 24, Kaitlib, Melodetta 24, Lopreeza, Gallifrey, Blisovi 24, Femlyv, XARAH, Feirza, Meleya, Jinteli, Lyleq, Loestrin 21, Briellyn, Activella, Aurovela, 24FE, OSHIH, Finzala, Luizza, Emzahh, Incassia, Tarina, Balziva, Tarina 24, Aranelle, Vyfemla, Etyqa, Jencycla, Myfembree, Fyavolv

FDA approval date: May 25, 2001

Classification: Progestin

Form: Tablet, Kit

What is Sharobel (Norethindrone Acetate)?

Aurovela.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Phase 1, 4-arm, Open-label, Drug-drug Interaction Trial to Evaluate the Pharmacokinetics of Repinatrabit Oral Tablets When Co-administered With Ethinyl Estradiol/Norethindrone, Metformin, Carbamazepine, Rosuvastatin, and Methotrexate in Healthy Participants

Enrollment Status: Recruiting

Publish Date: April 13, 2026

Intervention Type: Drug

Study Phase: Phase 1

Summary: The purpose of this study is to assess the drug-drug interaction (DDI) of repinatrabit with ethinyl estradiol/norethindrone or norethisterone (EE/NE), metformin, rosuvastatin, carbamazepine, and methotrexate in healthy participants.

Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for OligoRecurrenT Prostate Cancer (VA STARPORT)

Who is this study for: Patients with Prostate Cancer

Enrollment Status: Recruiting

Publish Date: April 08, 2026

Intervention Type: Drug, Procedure, Radiation, Other

Study Drugs: Goserelin, Histrelin, Leuprolide & Triptorelin, Androgen Deprivation Therapy + Nilutamide, Flutamide, & Bicalutamide, Degarelix, Androgen Deprivation Therapy + Docetaxel +/- Prednisone, Androgen Deprivation Therapy + Abiraterone + Prednisone, Androgen Deprivation Therapy + Abiraterone + Methylprednisolone, Androgen Deprivation Therapy + Apalutamide, Androgen Deprivation Therapy + Enzalutamide

Study Phase: Phase 2/Phase 3

Summary: This is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in improving the castration-resistant prostate cancer-free survival (CRPC-free survival) for Veterans with oligometastatic prostate cancer. Oligometastasis will be defined as 1-10 sites of metastatic disease based on the clinica...

Phase III Study of Local or Systemic Therapy INtensification DIrected by PET in Prostate CAncer Patients With Post-ProstaTEctomy Biochemical Recurrence (INDICATE)

Who is this study for: Adult patients with prostate cancer

Enrollment Status: Recruiting

Publish Date: April 03, 2026

Intervention Type: Procedure, Drug, Radiation, Other

Study Drugs: Apalutamide, Goserelin acetate, Leuprolide acetate

Study Phase: Phase 3

Summary: This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurre...

View All Clinical Trials